Clinical Trials Logo

Sleep clinical trials

View clinical trials related to Sleep.

Filter by:
  • Not yet recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06382610 Not yet recruiting - Sleep Clinical Trials

Pharmacokinetics of Melatonin Administered in Oral, Lotion, and Bubble Bath Formulations

Start date: May 10, 2024
Phase: N/A
Study type: Interventional

Melatonin is a hormone that promotes sleep that is available without a prescription in the United States. In addition to oral supplements, melatonin can be purchased in the form of lotions and bubble baths with unknown dosage and no frequency or age recommendations. In this study, researchers will examine how quickly melatonin in lotion and bubble bath is absorbed compared to oral tablets, as well as how long the melatonin lasts in the body.

NCT ID: NCT06378567 Not yet recruiting - Stress Clinical Trials

A Study to Assess the Effects of Dietary Supplement Drinks on Sleep, Stress and Mood

Start date: April 2024
Phase: N/A
Study type: Interventional

A home placement, randomized, double blind, placebo-controlled, study to determine the effect of dietary liquid shot beverage products on self-reported measures of sleep, stress and mood on generally healthy participants with current self-reported mild/moderate sleep difficulties (but not clinical insomnia) and mild/moderate stress.

NCT ID: NCT06347744 Not yet recruiting - Sleep Clinical Trials

Radicle Rest 24: A Study of Health and Wellness Products on Sleep and Related Health Outcomes

Start date: June 2024
Phase: N/A
Study type: Interventional

A randomized, double-blind, placebo-controlled study assessing the impact of health and wellness products on sleep and related health outcomes.

NCT ID: NCT06336590 Not yet recruiting - Stress Clinical Trials

Student Exercise and Sleep Timing Study - Part 2

SiESTa 2
Start date: May 10, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the effects of a morning exercise intervention on sleep (quality and duration), mood (positive affect, anxiety, depression, anger), stress and productivity among undergraduate students (18-23 years) evening-exercisers with poor self-reported sleep quality. Aim 1. Compared to the control condition, evening-exercisers prescribed morning exercise will exhibit improved sleep quality (increased efficiency, decreased fragmentation) and increased sleep duration. Aim 2. Compared to the control condition, evening-exercisers prescribed morning exercise will exhibit improved mood (increased positive affect, decreased depression, anxiety and anger). Aim 3. Compared to the control condition, evening-exercisers prescribed morning exercise will exhibit decreased stress and increased productivity.

NCT ID: NCT06300112 Not yet recruiting - Stress Clinical Trials

Prenatal Yoga on Stress, Quality of Sexual Life and Sleep Level

Start date: March 15, 2024
Phase: N/A
Study type: Interventional

The study will investigate the effects of pregnancy yoga on perceived stress, quality of sexual life and sleep level. A total of 100 pregnant women are planned to be included in the study. Data will be collected with the "Personal Information Form", "Perceived Stress Scale" and "Sexual Quality of Life Questionnaire-Female". Yoga will be applied to the experimental group for a total of 12 sessions, two sessions per week (90 minutes) for six weeks. The research predicts that yoga will reduce the stress perceived by pregnant women, increase the quality of sexual life and positively affect sleep patterns.

NCT ID: NCT06290063 Not yet recruiting - Depression Clinical Trials

Cannabidiol and Older Adult Cannabis Users

QUARTz
Start date: March 1, 2024
Phase: Phase 2
Study type: Interventional

Cannabis use increased 10 fold among adults over the age of 65 between 2014 and 2016 but very little data exists on the extent of their harmful effects on health and behavior. The overarching goal of this project is to test a novel harm reduction strategy in which older individuals who seek to use cannabis for pain, anxiety or mood problems (depression/anxiety) will be randomly assigned to one of three conditions in an 8 week randomized controlled trial: hemp-derived CBD+THC, hemp-derived CBD-THC, or placebo. This work has the ability to directly inform individual choices regarding the use of cannabis products among older adults, and direct policy decisions regulating cannabis formulations on the legal market.

NCT ID: NCT06266611 Not yet recruiting - Depression Clinical Trials

Cannabis for Palliative Care in Cancer

ARCTiC
Start date: March 1, 2024
Phase: Phase 2
Study type: Interventional

Many cancer patients suffer from pain, sleep, and mood problems and are using cannabis to relieve these symptoms. Cannabis may provide such relief but may also produce negative side effects including cognitive impairment, an especially problematic issue for cancer patients, indicating more research on cannabis use in the cancer context is required. In this endeavor, the present study seeks to compare the use of hemp-derived CBD (Cannabidiol) with and without THC (Delta-9-tetrahydrocannabinol) versus placebo on measures of sleep, pain, mood, subjective and objective cognitive functioning, and quality of life within 185 cancer patients.

NCT ID: NCT06262594 Not yet recruiting - Epilepsy Clinical Trials

Lemborexant Treatment of Insomnia Linked to Epilepsy

L'ÉTOILE
Start date: February 8, 2024
Phase: Phase 3
Study type: Interventional

The goal of this clinical trial is to assess whether Lemborexant can improve sleep in patients with epilepsy.

NCT ID: NCT06240325 Not yet recruiting - Sleep Clinical Trials

Sleep Promotion Program Primary Care

SPP PC
Start date: July 2024
Phase: N/A
Study type: Interventional

Investigators developed a brief, scalable, behavioral Sleep Promotion Program (SPP) for adolescents with short sleep duration and sleep-wake irregularity, which relies on two individual sessions and smart phone technology to deliver evidence-based strategies. This R34 will test the feasibility and initial effectiveness of the SPP program and provider training via pilot randomized controlled trial (RCT, n=50) comparing SPP to Sleep Psychoeducation, a brief session on healthy sleep habits. Participants will be adolescents (12-18 years) with short sleep duration, sleep-wake irregularity, and depression.

NCT ID: NCT06239792 Not yet recruiting - Sleep Clinical Trials

Sleep Promotion Program Primary Care (SPP PC) Open Trial

SPP OT
Start date: March 2024
Phase: N/A
Study type: Interventional

Investigators developed a brief, scalable, behavioral Sleep Promotion Program (SPP) for adolescents with short sleep duration and sleep-wake irregularity, which relies on one individual session and smart phone technology to deliver evidence-based strategies. This open trial portion of the R34 will focus on conducting an open trial (n=8) to iteratively refine provider training, implementation procedures, and SPP program, per participant and staff feedback.